Incyte Corporation (INCY)

Trade INCY now with
7/30/2019 7:06:21 AM Incyte Q2 EPS $0.48 Vs $0.24 Last Year
7/2/2019 7:35:18 AM Incyte And Zai Lab Announce Collaboration And License Agreement For INCMGA0012 In Greater China
6/15/2019 10:37:45 AM Incyte Announces Positive Results From Phase 2 Study Of Ruxolitinib Cream In Patients With Vitiligo
6/4/2019 7:32:53 AM Incyte Says First Patient Treated In FIGHT-302 Phase 3 Study
4/30/2019 7:07:06 AM Incyte Q1 EPS $0.47; Non-GAAP EPS $0.62
2/14/2019 7:03:28 AM Incyte Q4 EPS $0.32 Vs Loss $0.71 Last Year
2/7/2019 7:06:28 AM Incyte Says FDA Extended Review Period For Ruxolitinib In Acute Graft-Versus-Host Disease
2/4/2019 6:46:28 AM Lilly Says Baricitinib Meet Primary Endpoint In BREEZE-AD1 And BREEZE-AD2 Phase 3 Studies
1/22/2019 7:30:21 AM Incyte Announces First Patient Treated In Phase 3 Clinical Trial Of Itacitinib For Chronic Graft-Versus-Host Disease
1/7/2019 7:03:34 AM Merus Says FDA Accepted IND Application For MCLA-145